Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  FIRST NORTH STOCKHOLM  >  Biovica International AB (publ)    BIOVIC B   SE0008613731

BIOVICA INTERNATIONAL AB (PUBL)

(BIOVIC B)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Most relevant news about BIOVICA INTERNATIONAL AB (
01/16BIOVICA INTERNATIONAL PUBL : Clinical Cancer Research publishes results supporti..
AQ
2019BIOVICA INTERNATIONAL PUBL : strengthens management team
AQ
2019Q2 INTERIM REPORT : Work with the FDA application progressing as planned
PU
2019Q2 INTERIM REPORT :  Work with the FDA application progressing as planned
AQ
2019BIOVICA INTERNATIONAL PUBL : DiviTum validated as a dynamic biomarker in metasta..
PU
2019BIOVICA INTERNATIONAL PUBL : DiviTum - Strong prognostic marker in operable brea..
AQ
2019BIOVICA INTERNATIONAL PUBL : DiviTum validated as a dynamic biomarker in metasta..
AQ
2019BIOVICA INTERNATIONAL PUBL : strengthens with new R&D Director
AQ
2019BIOVICA ISO 13485 : 2016 certificate renewal
AQ
2019BIOVICA INTERNATIONAL PUBL : will present at the Biomarkers & Precision Medicine..
AQ
2019BIOVICA INTERNATIONAL : DiviTum® Included in New U.S. Cancer Study
AQ
2019BIOVICA INTERNATIONAL : invites to telephone conference/audiocast
AQ
2019BIOVICA INTERNATIONAL : New scientific publication focuses on DiviTum® and highl..
AQ
More most relevant news
All news about BIOVICA INTERNATIONAL AB (
01/16BIOVICA INTERNATIONAL PUBL : Clinical Cancer Research publishes results supporti..
AQ
2019BIOVICA INTERNATIONAL PUBL : strengthens management team
AQ
2019Q2 INTERIM REPORT : Work with the FDA application progressing as planned
PU
2019Q2 INTERIM REPORT :  Work with the FDA application progressing as planned
AQ
2019BIOVICA INTERNATIONAL PUBL : DiviTum validated as a dynamic biomarker in metasta..
PU
2019BIOVICA INTERNATIONAL PUBL : DiviTum - Strong prognostic marker in operable brea..
AQ
2019BIOVICA INTERNATIONAL PUBL : DiviTum validated as a dynamic biomarker in metasta..
AQ
2019BIOVICA INTERNATIONAL PUBL : strengthens with new R&D Director
AQ
2019BIOVICA ISO 13485 : 2016 certificate renewal
AQ
2019BIOVICA INTERNATIONAL PUBL : will present at the Biomarkers & Precision Medicine..
AQ
More news
News in other languages on BIOVICA INTERNATIONAL AB (

- No features available -

Press releases
01/16BIOVICA INTERNATIONAL PUBL : Clinical Cancer Research publishes results supporti..
AQ
2019BIOVICA INTERNATIONAL PUBL : strengthens management team
AQ
2019Q2 INTERIM REPORT : Work with the FDA application progressing as planned
PU
2019Q2 INTERIM REPORT :  Work with the FDA application progressing as planned
AQ
2019BIOVICA INTERNATIONAL PUBL : DiviTum validated as a dynamic biomarker in metasta..
PU
More press releases
Sector news : Bio Diagnostics & Testing
01/14Freeport Rules Out Deals in Near Term -- WSJ
DJ
01/13Freeport-McMoran Isn't Looking for Strategic Deals in Coming Years, CEO Says
DJ
01/13Novartis to speed access to $10 billion heart drug via NHS deal
RE
01/13Drugmakers Test New Ways to Pay for Six-Figure Treatments
DJ
01/08In a vigorous defense, Carlos Ghosn claims he has done nothing wrong
More sector news : Bio Diagnostics & Testing